Treatment outcome among HIV-TB coinfected patients treated with single dose Dolutegravir 50mg and rifampicin-based therapy in a single centre in Bayelsa, Nigeria
Introduction: Current guidelines in the treatment of HIV/Tb coinfection recommends dolutegravir 50mg twice daily use in combination with rifampicin. In our unit we inadvertently omitted boosting the dolutegravir in coinfected patients on rifampicin-based therapy in both the intensive and continuous...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | International Journal of Infectious Diseases |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971224008233 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|